Human infection with highly pathogenic avian influenza A viruses causes severe disease
and fatalities. We previously identified a potent and broadly neutralizing antibody (bnAb) …

mAbs constitute an important biological tool for influenza virus haemagglutinin (HA) epitope
mapping through the generation of escape mutants, which could provide insights into …

Most monoclonal antibodies (mAbs) generated from humans infected or vaccinated with the
2009 pandemic H1N1 (pdmH1N1) influenza virus targeted the hemagglutinin (HA) stem …

The human antibody response to influenza virus infection plays a protective role against re-
infection, yet little molecular detail is available regarding how human antibodies, when …

Despite available antivirals and vaccines, influenza continues to be a major cause of
mortality worldwide. Vaccination generally induces an effective, but strain-specific antibody …

Current influenza virus vaccines rely upon the accurate prediction of circulating virus strains
months in advance of the actual influenza season in order to allow time for vaccine …

Background Influenza virus remains a continuous and severe threat to public health
worldwide, and its prevention and treatment have always been a major international issue …

Influenza remains a serious public health threat throughout the world. Vaccines and
antivirals are available that can provide protection from infection. However, new viral strains …

The DiversitabTM system produces target specific high titer fully human polyclonal IgG
immunoglobulins from transchromosomic (Tc) bovines shown to be safe and effective …

Highly pathogenic avian H5N1 influenza viruses are endemic in poultry in Asia and pose a
pandemic threat to humans. Since the deployment of vaccines against a pandemic strain …